Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 99.60M | $ 82.30M | $ 119.10M | $ 48.40M | $ 267.00M |
Total Assets | $ 1.34B | $ 1.27B | $ 1.29B | $ 1.18B | $ 1.43B |
Total Debt | $ 327.60M | $ 354.60M | $ 361.80M | $ 380.50M | $ 678.20M |
Net Debt | $ 228.00M | $ 272.30M | $ 242.70M | $ 332.10M | $ 411.20M |
Total Liabilities | $ 873.10M | $ 829.50M | $ 868.30M | $ 814.20M | $ 1.14B |
Stockholders Equity | $ 465.60M | $ 440.60M | $ 423.20M | $ 370.50M | $ 276.50M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |